down arrow

Shilpa Medicare

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
622.00
11.35 (1.86%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.4 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

618.55634.00

52 Week

419.10959.95
Valuation
Technical
Day's Volume

CASH

1.4 lacs (-34.16%) Volume

Shareholding (Dec 2024)

FII

9.90%

Held by 92 FIIs

DII

8.27%

Held by 9 DIIs

Promoter

44.23%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.16%

  • Poor long term growth as Net Sales has grown by an annual rate of 7.05% and Operating profit at 3.86% over the last 5 years
2

Stock is technically in a Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 6,083 Cr (Mid Cap)

stock-summary
P/E

72.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.20

stock-summary
Return on Equity

2.39%

stock-summary
Price to Book

2.57

Revenue and Profits (1 Year):
Net Sales:
319 Cr
(Quarterly Results - Dec 2024)
Net Profit:
32 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-28.82%
0%
-28.82%
1 Year
21.46%
0%
21.46%
2 Years
132.22%
0%
132.22%
3 Years
30.63%
0.28%
30.91%
4 Years
60.85%
0.43%
61.28%
5 Years
99.42%
0.58%
100.0%

Latest dividend: 1.1 per share ex-dividend date: Sep-19-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.05%
EBIT Growth (5y)
3.86%
EBIT to Interest (avg)
3.50
Debt to EBITDA (avg)
4.17
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.44
Tax Ratio
34.50%
Dividend Payout Ratio
0
Pledged Shares
7.92%
Institutional Holding
18.17%
ROCE (avg)
5.26%
ROE (avg)
3.54%
Valuation key factors
Factor
Value
P/E Ratio
72
Industry P/E
33
Price to Book Value
2.57
EV to EBIT
32.30
EV to EBITDA
20.77
EV to Capital Employed
2.30
EV to Sales
5.17
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
6.68%
ROE (Latest)
2.39%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

7.9191

Mutual Funds

Held by 8 Schemes (4.89%)

FIIs

Held by 92 FIIs (9.9%)

Promoter with highest holding

Vishnukant Chaturbhuj Bhutada (6.51%)

Highest Public shareholder

Icici Prudential Elss Tax Saver Fund (2.4%)

Individual Investors Holdings

24.4%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -7.12% vs 17.53% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 77.15% vs 27.60% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "319.32",
          "val2": "343.80",
          "chgp": "-7.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "80.70",
          "val2": "86.01",
          "chgp": "-6.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "11.75",
          "val2": "25.55",
          "chgp": "-54.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.78",
          "val2": "17.94",
          "chgp": "77.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.27%",
          "val2": "25.02%",
          "chgp": "0.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 11.02% vs 9.37% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 1,046.95% vs 115.67% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "636.31",
          "val2": "573.15",
          "chgp": "11.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "159.61",
          "val2": "108.21",
          "chgp": "47.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "49.29",
          "val2": "41.38",
          "chgp": "19.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32.00",
          "val2": "2.79",
          "chgp": "1,046.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.08%",
          "val2": "18.88%",
          "chgp": "6.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 11.13% vs 9.33% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 765.40% vs 130.17% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "955.63",
          "val2": "859.91",
          "chgp": "11.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "240.31",
          "val2": "174.43",
          "chgp": "37.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "61.04",
          "val2": "67.60",
          "chgp": "-9.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "63.78",
          "val2": "7.37",
          "chgp": "765.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.15%",
          "val2": "20.28%",
          "chgp": "4.87%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 9.66% vs -8.33% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 198.12% vs -153.54% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,151.60",
          "val2": "1,050.11",
          "chgp": "9.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "244.49",
          "val2": "102.28",
          "chgp": "139.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "91.81",
          "val2": "58.65",
          "chgp": "56.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.13",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.87",
          "val2": "-32.48",
          "chgp": "198.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.23%",
          "val2": "9.74%",
          "chgp": "11.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
319.32
343.80
-7.12%
Operating Profit (PBDIT) excl Other Income
80.70
86.01
-6.17%
Interest
11.75
25.55
-54.01%
Exceptional Items
0.00
0.00
Consolidate Net Profit
31.78
17.94
77.15%
Operating Profit Margin (Excl OI)
25.27%
25.02%
0.25%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -7.12% vs 17.53% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 77.15% vs 27.60% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
636.31
573.15
11.02%
Operating Profit (PBDIT) excl Other Income
159.61
108.21
47.50%
Interest
49.29
41.38
19.12%
Exceptional Items
0.00
0.00
Consolidate Net Profit
32.00
2.79
1,046.95%
Operating Profit Margin (Excl OI)
25.08%
18.88%
6.20%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 11.02% vs 9.37% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 1,046.95% vs 115.67% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
955.63
859.91
11.13%
Operating Profit (PBDIT) excl Other Income
240.31
174.43
37.77%
Interest
61.04
67.60
-9.70%
Exceptional Items
0.00
0.00
Consolidate Net Profit
63.78
7.37
765.40%
Operating Profit Margin (Excl OI)
25.15%
20.28%
4.87%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 11.13% vs 9.33% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 765.40% vs 130.17% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,151.60
1,050.11
9.66%
Operating Profit (PBDIT) excl Other Income
244.49
102.28
139.04%
Interest
91.81
58.65
56.54%
Exceptional Items
6.13
0.00
Consolidate Net Profit
31.87
-32.48
198.12%
Operating Profit Margin (Excl OI)
21.23%
9.74%
11.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 9.66% vs -8.33% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 198.12% vs -153.54% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Shilpa Medicare Ltd stock-summary
stock-summary
Shilpa Medicare Ltd
Mid Cap
Pharmaceuticals & Drugs
Shilpa Medicare Limited (Formerly known as Shilpa Antibiotics Private Limited) was incorporated as a Private Limited Company on November 20, 1987. The Company changed the status to Public Limited and the name of the Company was changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C.
Company Coordinates stock-summary
Company Details
#12-6-214/A1, Hyderabad Road Raichur Karnataka : 584135
stock-summary
Tel: 91-8532-238704
stock-summary
http://www.vbshilpa.com
stock-summary
info@vbshilpa.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."